ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
8,004.50
-0.16%
S&P ASX All Technology
3,177.20
0.39%
Brent Oil
84.09
-0.30%
US Dollar vs AUD
1.48156
0.20%
Bitcoin
64,663.37
-0.29%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. PureTech Health PLC (PRTC)

  7. PureTech Health PLC (PRTC) News

PRTC

PureTech Health (PRTC)

PureTech Health PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRTC
DateTimeSourceHeadlineSymbolCompany
26/01/202223:02Business WirePureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. INASDAQ:PRTCPureTech Health PLC
14/01/202218:00Business WirePureTech Founded Entity Gelesis, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of its Business Combination with CapstarNASDAQ:PRTCPureTech Health PLC
07/01/202223:30TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Aligos Therapeutics (ALGS), PureTech Health (PRTC)NASDAQ:PRTCPureTech Health PLC
07/01/202223:00Business WirePureTech to Present at 40th Annual J.P. Morgan Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
06/01/202218:00Business WirePureTech’s LYT-100 (Deupirfenidone) Achieves 50% Reduction in Healthy Older Adults Experiencing GI-Related Adverse Events Compared to PirfenidoneNASDAQ:PRTCPureTech Health PLC
05/01/202223:05Business WirePureTech Founded Entity Gelesis Appoints Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit CommitteeNASDAQ:PRTCPureTech Health PLC
21/12/202121:55TipRanksLeerink Partners Thinks PureTech Health’s Stock is Going to RecoverNASDAQ:PRTCPureTech Health PLC
16/12/202118:00Business WirePureTech Provides End of Year Report on Key Progress Across Wholly Owned Programs and Founded EntitiesNASDAQ:PRTCPureTech Health PLC
08/12/202123:00Business WirePureTech Presents Preclinical Proof-of-Concept Data for LYT-300 (Oral Allopregnanolone) as Potential Treatment for Neurological and Neuropsychological ConditionsNASDAQ:PRTCPureTech Health PLC
07/12/202123:00Business WirePureTech Advances Wholly-Owned Candidate LYT-300 (Oral Allopregnanolone) into Clinical Study for Potential Treatment of Neurological and Neuropsychological ConditionsNASDAQ:PRTCPureTech Health PLC
01/12/202123:10Business WirePureTech Founded Entity Gelesis Announces FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition OfficerNASDAQ:PRTCPureTech Health PLC
18/11/202123:10Business WirePureTech Founded Entity Gelesis Receives $30 Million Plenity® Order from RoNASDAQ:PRTCPureTech Health PLC
16/11/202123:00Business WirePureTech Announces Publication of Phase 1 Results for LYT-100 in the Journal Clinical Pharmacology in Drug Development and Provides Timing UpdatesNASDAQ:PRTCPureTech Health PLC
15/11/202123:00Business WirePureTech Announces Participation in Two Upcoming Investor ConferencesNASDAQ:PRTCPureTech Health PLC
12/11/202123:00Business WirePureTech Presents Clinical Trial Design Supporting Wholly Owned Immuno-Oncology Candidate LYT-200 at the Society for Immunotherapy of Cancer (SITC) 36th Annual MeetingNASDAQ:PRTCPureTech Health PLC
11/11/202123:00Business WirePureTech Receives Orphan Drug Designation for Wholly Owned Candidate LYT-200 for the Treatment of Pancreatic CancerNASDAQ:PRTCPureTech Health PLC
10/11/202122:11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
09/11/202123:37Business WirePureTech Founded Entity Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater ChinaNASDAQ:PRTCPureTech Health PLC
09/11/202118:00Business WirePureTech Announces Participation at the Jefferies London Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
01/11/202121:20Business WirePureTech Is Pleased to Note Publication in Nature’s Scientific Reports Featuring the Gelesis Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut DamageNASDAQ:PRTCPureTech Health PLC
14/10/202122:01Business WirePureTech Founded Entity Vedanta Biosciences Appoints Simona Levi as Chief Legal Officer and Corporate SecretaryNASDAQ:PRTCPureTech Health PLC
12/10/202121:11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
05/10/202123:01Business WirePureTech Founded Entity Vedanta Announces Positive Topline Phase 2 Data for VE303 in High-Risk C. difficile Infection and Exercise of $23.8 Million Option by BARDANASDAQ:PRTCPureTech Health PLC
05/10/202123:00Business WirePureTech Founded Entity Sonde Health Launches Vocal Biomarker Technology to Monitor Mental Health and Well-BeingNASDAQ:PRTCPureTech Health PLC
29/09/202122:02Business WirePureTech Founded Entity Akili Announces Topline Results from Shionogi Phase 2 Study in JapanNASDAQ:PRTCPureTech Health PLC
21/09/202101:04Business WirePureTech Announces Publication of New Preclinical Research from Collaborators that Supports Mesenteric Lymphatic Dysfunction as a Potential Cause of and Therapeutic Target for Obesity and Insulin ResistanceNASDAQ:PRTCPureTech Health PLC
14/09/202121:00Business WirePureTech to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech SummitNASDAQ:PRTCPureTech Health PLC
10/09/202116:00Business WirePureTech Founded Entity Vor Biopharma Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid LeukemiaNASDAQ:PRTCPureTech Health PLC
24/08/202120:56Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
24/08/202116:00Business WirePureTech Health plc – Half-Year ReportNASDAQ:PRTCPureTech Health PLC
 Showing the most relevant articles for your search:NASDAQ:PRTC

Your Recent History

BIT
P1NIY7
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved